DRREDDY had a strong weekly performance, returning 2.62% with a Sharpe Ratio of 2.32, indicating a high risk-adjusted return. The stock's volatility was relatively low at 4.45%, making it a less risky investment option. Compared to its peers, DRREDDY outperformed DIVISLAB and HINDUNILVR, but underperformed SUNPHARMA. Overall, the stock's performance was impressive, with a low max drawdown of 0.0%.

[Volatility: 4.45%]